Novel |
ADRA2B |
adrenoceptor alpha 2B |
- Adrenoceptors
- Adrenaline signalling through Alpha-2 adrenergic receptor
- G alpha (i) signalling events
- G alpha (z) signalling events
|
- Amphetamine
- Tramadol
- Bethanidine
- Ziprasidone
- Cabergoline
- Ropinirole
- Etomidate
- Dihydroergotamine
- Clozapine
- Norepinephrine
- Phenylpropanolamine
- Loxapine
- Prochlorperazine
- Prazosin
- Chlorpromazine
- Brimonidine
- Haloperidol
- Nortriptyline
- Amoxapine
- Clonidine
- Lisuride
- Guanabenz
- Epinephrine
- Tizanidine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Tolazoline
- Fenoldopam
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Apraclonidine
- Guanfacine
- Ergoloid mesylate
- Promethazine
- Carvedilol
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Paliperidone
- Ephedra sinica root
- Mephentermine
- Yohimbine
- Methotrimeprazine
- Dextroamphetamine
- Metamfetamine
- Celiprolol
- Dronedarone
- Rotigotine
- OPC-28326
- Epicept NP-1
- Mianserin
- Pizotifen
- Asenapine
- Ocaperidone
- Droxidopa
- Esmirtazapine
- Xylometazoline
- Levonordefrin
- Tetryzoline
- Dosulepin
- Etoperidone
- Lorpiprazole
- Cirazoline
- Moxisylyte
- Aranidipine
- Setiptiline
- Racepinephrine
- Dihydroergocornine
- DL-Methylephedrine
- Xylazine
- Indigotindisulfonic acid
- Tiapride
- Dihydroergocristine
- Aripiprazole lauroxil
|
|
Novel |
FAM32A |
family with sequence similarity 32 member A |
- mRNA Splicing - Major Pathway
|
|
|
Novel |
JAML |
junction adhesion molecule like |
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Cell surface interactions at the vascular wall
|
|
|
Novel |
TPSAB1 |
tryptase alpha/beta 1 |
- Activation of Matrix Metalloproteinases
|
- 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine
- 1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine
|
|
|
A2M |
alpha-2-macroglobulin |
- Platelet degranulation
- Intrinsic Pathway of Fibrin Clot Formation
- Degradation of the extracellular matrix
- HDL assembly
|
- Becaplermin
- Cisplatin
- Bacitracin
- Zinc
- Ocriplasmin
- Silver
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
ACAN |
aggrecan |
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Keratan sulfate biosynthesis
- Keratan sulfate degradation
- ECM proteoglycans
- Defective CHST6 causes MCDC1
- Defective ST3GAL3 causes MCT12 and EIEE15
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
|
|
- Familial osteochondritis dissecans; Osteochondritis dissecans, short stature, and early-onset osteoarthritis
- Spondyloepiphyseal dysplasia, Kimberley type
|
|
CFTR |
CF transmembrane conductance regulator |
- ABC-family proteins mediated transport
- RHO GTPases regulate CFTR trafficking
- Defective CFTR causes cystic fibrosis
- Ub-specific processing proteases
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- RHOQ GTPase cycle
- Chaperone Mediated Autophagy
- Late endosomal microautophagy
- Aggrephagy
- Aggrephagy
- Developmental Lineage of Pancreatic Ductal Cells
|
- ATP
- Bumetanide
- Glyburide
- Ibuprofen
- Genistein
- Colforsin
- Phosphoaminophosphonic Acid-Adenylate Ester
- Dexfosfoserine
- Crofelemer
- Lonidamine
- Ivacaftor
- Dexibuprofen
- Lumacaftor
- Tezacaftor
- Elexacaftor
|
- Hereditary pancreatitis; Hereditary chronic pancreatitis
- Cystic fibrosis (CF)
- Congenital bilateral absence of vas deferens
|
|
DYRK1A |
dual specificity tyrosine phosphorylation regulated kinase 1A |
|
- N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
- Fostamatinib
|
|
|
FURIN |
furin, paired basic amino acid cleaving enzyme |
- Signaling by NODAL
- Collagen degradation
- Collagen degradation
- Elastic fibre formation
- Activation of Matrix Metalloproteinases
- Removal of aminoterminal propeptides from gamma-carboxylated proteins
- NGF processing
- Synthesis and processing of ENV and VPU
- Signaling by PDGF
- Pre-NOTCH Processing in Golgi
- TGF-beta receptor signaling activates SMADs
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Uptake and function of anthrax toxins
- Formation of the cornified envelope
- Assembly of active LPL and LIPC lipase complexes
- CD163 mediating an anti-inflammatory response
- Potential therapeutics for SARS
- Attachment and Entry
- Induction of Cell-Cell Fusion
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
- Amyloid fiber formation
- Respiratory syncytial virus (RSV) attachment and entry
- Maturation of hRSV A proteins
|
|
|
|
KRT40 |
keratin 40 |
- Keratinization
- Formation of the cornified envelope
|
|
|
|
KRTAP10-8 |
keratin associated protein 10-8 |
|
|
|
|
VCAN |
versican |
- Glycosaminoglycan-protein linkage region biosynthesis
- CS-GAG biosynthesis
- DS-GAG biosynthesis
- CS/DS degradation
- ECM proteoglycans
- Defective B4GALT7 causes EDS, progeroid type
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective CHST14 causes EDS, musculocontractural type
- Defective CHSY1 causes TPBS
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Defective B3GALT6 causes EDSP2 and SEMDJL1
- Post-translational protein phosphorylation
|
|
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
|
|
VEGFA |
vascular endothelial growth factor A |
- Platelet degranulation
- Regulation of gene expression by Hypoxia-inducible Factor
- Signaling by VEGF
- VEGF ligand-receptor interactions
- VEGF binds to VEGFR leading to receptor dimerization
- Interleukin-4 and Interleukin-13 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
|
- Bevacizumab
- Minocycline
- Gliclazide
- Carvedilol
- Ranibizumab
- Pidolic acid
- Pegaptanib
- Vandetanib
- ABT-510
- Veglin
- Denibulin
- SNS-032
- Bevasiranib
- Dalteparin
- Aflibercept
- Chondroitin sulfate
- Foreskin keratinocyte (neonatal)
- Vanucizumab
- Brolucizumab
- Faricimab
|
|